Non-small cell lung cancer (stage III)
Clinical trials for Non-small cell lung cancer (stage III) explained in plain language.
Never miss a new study
Get alerted when new Non-small cell lung cancer (stage III) trials appear
Sign up with your email to follow new studies for Non-small cell lung cancer (stage III), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to shrink inoperable lung tumors enough for surgery
Disease control Not yet recruitingThis study tests a combination of two drugs, sacituzumab tirumotecan and toripalimab, in 50 people with stage III non-small cell lung cancer that cannot be surgically removed. The goal is to see if the treatment can shrink tumors enough to allow surgery, and to measure how long t…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase 2 • Sponsor: Hunan Province Tumor Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug hopes to keep stage III lung cancer at bay after Chemo-Radiation
Disease control Not yet recruitingThis study tests whether a drug called ivonescimab can help prevent lung cancer from growing back after standard chemoradiation. It involves 63 adults with stage III non-small cell lung cancer that cannot be removed by surgery. Participants will receive ivonescimab infusions for …
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC